Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma

Background: Although the introduction of protease inhibitor bortezomib (BTZ) and immunomodulatory agent lenalidomide has led to improved outcomes in patients with multiple myeloma (MM), the disease remains incurable. Gambogenic acid (GNA), a polyprenylated xanthone isolated from the traditional Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Runzhe, Zhang, Hongming, Liu, Ping, Wu, Xue, Chen, Baoan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381173/
https://www.ncbi.nlm.nih.gov/pubmed/28382147
http://dx.doi.org/10.7150/jca.17657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381173/
https://www.ncbi.nlm.nih.gov/pubmed/28382147
http://dx.doi.org/10.7150/jca.17657

Ejemplares similares